Primary Results of GUIDANCE Clinical Study Evaluating NGAL Performance for Pediatric AKI Risk Assessment
Thursday, November 2 | 10 am-noon | POSTER # TH-PO512
NGAL Reference Intervals for Healthy Individuals
Saturday, November 4 | 10 am-noon | POSTER # SA-PO107
See you in the Exhibit Hall - Booth 1836
Learn more about the NGAL biomarker for acute kidney injury in critically ill patients: Know earlier. Manage better. With confidence.